Monarch Partners Asset Management LLC acquired a new position in Adeptus Health Inc. (NYSE:ADPT) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 4,220 shares of the company’s stock, valued at approximately $218,000.
Several other institutional investors also recently made changes to their positions in the company. Seven Eight Capital LLC acquired a new position in shares of Adeptus Health during the first quarter worth about $101,000. Royal Bank of Canada boosted its stake in shares of Adeptus Health by 1,036.6% in the first quarter. Royal Bank of Canada now owns 2,330 shares of the company’s stock worth $130,000 after buying an additional 2,125 shares in the last quarter. Springbok Capital Management LLC purchased a new stake in shares of Adeptus Health during the first quarter worth $151,000. M&T Bank Corp purchased a new stake in shares of Adeptus Health during the first quarter worth $216,000. Finally, BNP Paribas Arbitrage SA boosted its stake in shares of Adeptus Health by 124.6% in the second quarter. BNP Paribas Arbitrage SA now owns 4,169 shares of the company’s stock worth $215,000 after buying an additional 2,313 shares in the last quarter.
Adeptus Health Inc. (NYSE:ADPT) traded down 0.20% during midday trading on Friday, hitting $39.65. The stock had a trading volume of 248,759 shares. Adeptus Health Inc. has a one year low of $35.33 and a one year high of $90.71. The firm has a market cap of $648.28 million, a PE ratio of 6.04 and a beta of 0.96. The stock has a 50-day moving average price of $41.31 and a 200 day moving average price of $52.29.
Adeptus Health (NYSE:ADPT) last issued its quarterly earnings data on Thursday, July 21st. The company reported $0.48 earnings per share for the quarter, missing analysts’ consensus estimates of $0.51 by $0.03. Adeptus Health had a net margin of 22.99% and a return on equity of 14.74%. The business had revenue of $100.20 million for the quarter, compared to analyst estimates of $93.92 million. During the same quarter last year, the business earned $0.44 EPS. Adeptus Health’s revenue for the quarter was up 36.2% compared to the same quarter last year. On average, analysts predict that Adeptus Health Inc. will post $2.46 earnings per share for the current year.
A number of brokerages have weighed in on ADPT. Zacks Investment Research cut Adeptus Health from a “buy” rating to a “strong sell” rating in a research note on Wednesday, July 13th. Jefferies Group reiterated a “buy” rating and issued a $113.00 price objective (down previously from $125.00) on shares of Adeptus Health in a research note on Monday, July 11th. Goldman Sachs Group Inc. set a $80.00 price objective on Adeptus Health and gave the company a “buy” rating in a research note on Thursday, September 8th. Finally, JMP Securities reiterated a “buy” rating on shares of Adeptus Health in a research note on Thursday, September 22nd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $86.50.
Adeptus Health Company Profile
Adeptus Health Inc is a patient-centered healthcare company. The Company is engaged in providing emergency medical care through a network of independent freestanding emergency rooms in the United States and partnerships with various healthcare systems. The Company has approximately 80 freestanding facilities and over two licensed general hospitals.
Want to see what other hedge funds are holding ADPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Adeptus Health Inc. (NYSE:ADPT).
Receive News & Ratings for Adeptus Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adeptus Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.